Investigation of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease.

ABSTRACT:

Background

Dual antiplatelet therapy (DAPT) is currently the standard treatment for the prevention of ischemic events after stent implantation. However, the optimal DAPT duration remains elusive for patients with chronic kidney disease (CKD). Therefore, we aimed to compare the effectiveness and safety between long-term and short-term DAPT after coronary stenting in patients with CKD.

Methods

This retrospective cohort study analyze data from the Taipei Medical University (TMU) Institutional and Clinical Database, which include anonymized electronic health data of 3 million patients that visited TMU Hospital, Wan Fang Hospital, and Shuang Ho Hospital. We enrolled patients with CKD after coronary stenting between 2008 and 2019. The patients were divided into the long-term (>6 m

SUBMITTER: Kao CC 

PROVIDER: S-EPMC8336855 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature